MIH
HSTO

Meitav Investment House’s Histogen Inc. Common Stock HSTO Stock Holding History

Meitav Investment House’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,200
Closed -$94K – 431
2021
Q3 		$94K Hold
6,200
– – ﹤0.01% 394
2021
Q2 		$135K Buy
6,200
+2,500
+68% +$51.9K ﹤0.01% 397
2021
Q1 		$96 Buy
+3,700
New +$92.9K ﹤0.01% 369

Other funds holding HSTO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Meitav Investment House's HSTO Position: Q4 2021 in Review

Meitav Investment House sold out of Histogen Inc. Common Stock (HSTO) in Q4 2021, closing a stake of 6,200 shares — an estimated $94K sold.

Meitav Investment House first reported a position in HSTO in Q1 2021 and held it in 3 quarters. The position peaked at $135K in Q2 2021. 24 funds tracked by Wall St. Rank hold HSTO as of Q4 2021.

  • Meitav Investment House reported no remaining Histogen Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Meitav Investment House sold 6,200 Histogen Inc. Common Stock shares in Q4 2021, an estimated $94K.
  • Meitav Investment House first reported a position in Histogen Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Meitav Investment House's Histogen Inc. Common Stock position peaked at $135K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2021.

Based on Meitav Investment House's 13F filing for Q4 2021, filed 8 Feb 2022.